H. Michael Shepard
2009
In 2009, H. Michael Shepard earned a total compensation of $802.8K as Vice President and Chief Scientific Officer at Halozyme Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $32,603 |
|---|---|
| Option Awards | $557,390 |
| Salary | $152,744 |
| Other | $60,112 |
| Total | $802,849 |
Shepard received $557.4K in option awards, accounting for 69% of the total pay in 2009.
Shepard also received $32.6K in non-equity incentive plan, $152.7K in salary and $60.1K in other compensation.
Rankings
In 2009, H. Michael Shepard's compensation ranked 5,169th out of 9,885 executives tracked by ExecPay. In other words, Shepard earned more than 47.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,169 out of 9,885 | 48th |
Division Manufacturing | 1,852 out of 3,690 | 50th |
Major group Chemicals And Allied Products | 380 out of 866 | 56th |
Industry group Drugs | 236 out of 638 | 63rd |
Industry Biological Products, Except Diagnostic Substances | 42 out of 133 | 68th |
Source: SEC filing on March 29, 2012.
Shepard's colleagues
We found eight more compensation records of executives who worked with H. Michael Shepard at Halozyme Therapeutics in 2009.
2009
Jonathan Leff
Halozyme Therapeutics
Chief Medical Officer
2009
Kurt Gustafson
Halozyme Therapeutics
Chief Financial Officer
2009
Jonathan Lim
Halozyme Therapeutics
Chief Executive Officer
2009
Gregory Frost
Halozyme Therapeutics
Chief Executive Officer
2009
William Fallon
Halozyme Therapeutics
Vice President, Manufacturing & Operations
2009
David Ramsay
Halozyme Therapeutics
Vice President Corporate Development
2009
Robert Little
Halozyme Therapeutics
Vice President and Chief Commercial Officer
2009
Michael LaBarre
Halozyme Therapeutics